MXPA03007395A - Derivados de pirimidin-5-carboxamida 2,4-disustituida como moduladores del canal de potasio kcnq. - Google Patents
Derivados de pirimidin-5-carboxamida 2,4-disustituida como moduladores del canal de potasio kcnq.Info
- Publication number
- MXPA03007395A MXPA03007395A MXPA03007395A MXPA03007395A MXPA03007395A MX PA03007395 A MXPA03007395 A MX PA03007395A MX PA03007395 A MXPA03007395 A MX PA03007395A MX PA03007395 A MXPA03007395 A MX PA03007395A MX PA03007395 A MXPA03007395 A MX PA03007395A
- Authority
- MX
- Mexico
- Prior art keywords
- potassium channel
- channel modulators
- carboxamide derivatives
- kcnq potassium
- disubstituted pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26980001P | 2001-02-20 | 2001-02-20 | |
| PCT/US2002/004305 WO2002066036A1 (en) | 2001-02-20 | 2002-02-14 | 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03007395A true MXPA03007395A (es) | 2003-12-04 |
Family
ID=23028698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03007395A MXPA03007395A (es) | 2001-02-20 | 2002-02-14 | Derivados de pirimidin-5-carboxamida 2,4-disustituida como moduladores del canal de potasio kcnq. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20020183335A1 (es) |
| EP (1) | EP1361879A1 (es) |
| JP (1) | JP2005508833A (es) |
| CA (1) | CA2438231A1 (es) |
| CZ (1) | CZ20032233A3 (es) |
| HU (1) | HUP0303841A2 (es) |
| MX (1) | MXPA03007395A (es) |
| NO (1) | NO20033683L (es) |
| PL (1) | PL372944A1 (es) |
| WO (1) | WO2002066036A1 (es) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2463989C (en) * | 2001-10-17 | 2012-01-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof |
| WO2003032994A2 (de) * | 2001-10-17 | 2003-04-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren |
| US7205307B2 (en) | 2002-02-14 | 2007-04-17 | Icagen, Inc. | Pyrimidines as novel openers of potassium ion channels |
| US7176310B1 (en) * | 2002-04-09 | 2007-02-13 | Ucb Sa | Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents |
| UY27939A1 (es) | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | Compuestos |
| AU2003260436A1 (en) * | 2002-08-21 | 2004-03-11 | Glaxo Group Limited | Pyrimidine compounds |
| US7459460B2 (en) * | 2003-05-28 | 2008-12-02 | Bristol-Myers Squibb Company | Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
| TW200519094A (en) * | 2003-07-02 | 2005-06-16 | Vertex Pharma | Pyrimidines useful as modulators of voltage-gated ion channels |
| TWI338000B (en) * | 2003-12-01 | 2011-03-01 | Kudos Pharm Ltd | Dna damage repair inhibitors for treatment of cancer |
| GB0402356D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
| GB0404105D0 (en) * | 2004-02-24 | 2004-03-31 | Glaxo Group Ltd | Novel compounds |
| TWI357901B (en) * | 2004-03-12 | 2012-02-11 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivati |
| CA2561895A1 (en) | 2004-04-13 | 2005-10-27 | Icagen, Inc. | Polycyclic pyrimidines as potassium ion channel modulators |
| DE602005015742D1 (de) * | 2004-10-22 | 2009-09-10 | Janssen Pharmaceutica Nv | Aromatische amide als hemmer der c-fms-kinase |
| EP1809290A2 (en) | 2004-11-03 | 2007-07-25 | Vertex Pharmaceuticals Incorporated | Pyrimidine derivatives as ion channel modulators and methods of use |
| UA92340C2 (en) * | 2005-03-03 | 2010-10-25 | Х. Луннбек А/С | Substituted pyridine derivatives |
| JP5237643B2 (ja) | 2005-03-03 | 2013-07-17 | ハー・ルンドベック・アクチエゼルスカベット | 置換されたピリジン誘導体 |
| JP2008534472A (ja) * | 2005-03-22 | 2008-08-28 | ノイロサーチ アクティーゼルスカブ | カリウムチャンネル調節剤としてのピラゾリル−ピリミジン及びその医学的使用 |
| DE102005038947A1 (de) | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
| EP1904491A2 (en) * | 2005-05-31 | 2008-04-02 | Vertex Pharmaceuticals Incorporated | Heterocycles useful as modulators of ion channels |
| KR20080043314A (ko) * | 2005-09-09 | 2008-05-16 | 하. 룬트벡 아크티에 셀스카브 | 피리미딘 유도체 및 ｋｃｎｑ 포타슘 채널 개방제로서의그의 용도 |
| US7683058B2 (en) | 2005-09-09 | 2010-03-23 | H. Lundbeck A/S | Substituted pyrimidine derivatives |
| JP2010519328A (ja) | 2007-02-26 | 2010-06-03 | ファイザー・プロダクツ・インク | Ｈ−ｐｇｄｓの阻害剤としてのニコチンアミド誘導体およびプロスタグランジンｄ２が媒介する疾患の治療のためのそれらの使用 |
| JP5557832B2 (ja) * | 2008-03-18 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 置換４−ヒドロキシピリジン−５−カルボキサミド |
| TWI504395B (zh) | 2009-03-10 | 2015-10-21 | Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier | |
| TW201038565A (en) | 2009-03-12 | 2010-11-01 | Gruenenthal Gmbh | Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators |
| TWI461197B (zh) | 2009-03-12 | 2014-11-21 | 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier | |
| TWI475020B (zh) * | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
| CN102971307A (zh) * | 2010-07-08 | 2013-03-13 | 辉瑞大药厂 | 作为kv7钾通道开放剂的哌啶基嘧啶酰胺 |
| TWI522349B (zh) | 2010-08-27 | 2016-02-21 | 歌林達股份有限公司 | 作為ｋｃｎｑ２／３調節劑之被取代之２－氧基－喹啉－３－甲醯胺 |
| CA2809287C (en) | 2010-08-27 | 2018-05-22 | Gruenenthal Gmbh | Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators |
| MX2013000748A (es) | 2010-08-27 | 2013-03-05 | Gruenenthal Gmbh | 2-amino-quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3. |
| AU2011297937B2 (en) | 2010-09-01 | 2015-10-01 | Grunenthal Gmbh | Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators |
| US9168259B2 (en) | 2010-10-20 | 2015-10-27 | Grünenthal GmbH | Substituted 6-amino-nicotinamides as KCNQ2/3 modulators |
| WO2012052167A1 (en) | 2010-10-20 | 2012-04-26 | Grünenthal GmbH | Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| WO2013156155A1 (en) | 2012-04-18 | 2013-10-24 | Grünenthal GmbH | Substituted 4-aminobenzamides as kcnq2/3 modulators |
| WO2013156154A1 (en) * | 2012-04-18 | 2013-10-24 | Grünenthal GmbH | Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators |
| US9248122B2 (en) | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
| US20140148454A1 (en) * | 2012-11-28 | 2014-05-29 | Grünenthal GmbH | Substituted amino-acrylcarboxamides as kcnq2/3 modulators |
| BR112015012418A2 (pt) | 2012-11-28 | 2017-07-11 | Gruenenthal Gmbh | carboxamidas específicas como moduladores de kcnq2/3 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811428A (en) * | 1995-12-18 | 1998-09-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| US5852028A (en) * | 1995-12-18 | 1998-12-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
| US5935966A (en) * | 1995-09-01 | 1999-08-10 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
| US6274588B1 (en) * | 1999-05-31 | 2001-08-14 | Hoffmann-La Roche Inc. | 4-phenyl-pyrimidine derivatives |
| EP1200086A4 (en) * | 1999-08-04 | 2009-05-27 | Icagen Inc | THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY |
| WO2002072088A2 (en) * | 2001-02-20 | 2002-09-19 | Bristol-Myers Squibb Company | Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
-
2002
- 2002-02-14 WO PCT/US2002/004305 patent/WO2002066036A1/en not_active Application Discontinuation
- 2002-02-14 CZ CZ20032233A patent/CZ20032233A3/cs unknown
- 2002-02-14 US US10/075,521 patent/US20020183335A1/en not_active Abandoned
- 2002-02-14 CA CA002438231A patent/CA2438231A1/en not_active Abandoned
- 2002-02-14 HU HU0303841A patent/HUP0303841A2/hu unknown
- 2002-02-14 JP JP2002565594A patent/JP2005508833A/ja active Pending
- 2002-02-14 EP EP02709517A patent/EP1361879A1/en not_active Withdrawn
- 2002-02-14 MX MXPA03007395A patent/MXPA03007395A/es unknown
- 2002-02-14 PL PL02372944A patent/PL372944A1/xx not_active Application Discontinuation
-
2003
- 2003-08-19 NO NO20033683A patent/NO20033683L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20033683L (no) | 2003-10-17 |
| JP2005508833A (ja) | 2005-04-07 |
| PL372944A1 (en) | 2005-08-08 |
| EP1361879A1 (en) | 2003-11-19 |
| CA2438231A1 (en) | 2002-08-29 |
| WO2002066036A1 (en) | 2002-08-29 |
| HUP0303841A2 (hu) | 2004-03-01 |
| CZ20032233A3 (cs) | 2004-12-15 |
| NO20033683D0 (no) | 2003-08-19 |
| US20020183335A1 (en) | 2002-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03007395A (es) | Derivados de pirimidin-5-carboxamida 2,4-disustituida como moduladores del canal de potasio kcnq. | |
| MXPA03007093A (es) | Nueva composicion. | |
| MXPA03009558A (es) | Compuestos novedosos. | |
| ZA200501431B (en) | 5-Aryltetrazole compounds, compositions thereof, and uses therefor. | |
| IL158688A0 (en) | Native wi-fi architecture for 802.11 networks | |
| ZA200309521B (en) | Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives. | |
| GB2390091B (en) | Bisarylamines as potassium channel openers | |
| AU2003257437A1 (en) | Novel 2,5-disubstituted pyrimidine derivatives | |
| HK1069171A1 (en) | Substituted 6H-dibenzioÄc,hÜchromenes as estrogenic agents. | |
| MXPA03007320A (es) | Nuevos compuestos de pirimidina. | |
| MXPA03009698A (es) | Vacuna multivalente que comprende un antigeno vih y un antigeno vsh y/o un antigeno vph. | |
| MXPA03006603A (es) | Agonista de subtipo de receptor 5-ht1a. | |
| MXPA03007693A (es) | Composicion para la piel. | |
| MXPA03007539A (es) | Composicion herbicida. | |
| DE60210598D1 (de) | 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA | |
| MXPA03008139A (es) | Fluoralcoxifenilsulfonilureas sustituidas. | |
| AU2002334663A1 (en) | Kv3.3b potassium channel disruptions, compositions and methods related thereto | |
| MXPA03007314A (es) | Composicion para la piel para reducir aceites y grasa de la piel. | |
| MXPA03001269A (es) | Nuevos derivados de aminociclohexano. | |
| EG23378A (en) | Composition. | |
| MXPA03004166A (es) | Nuevos usos de combinaciones de agonistas de 5-ht1a e inhibidores de la recaptacion de serotonina. | |
| DE60213084D1 (de) | 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA | |
| MXPA03008394A (es) | Derivados de biuretano. | |
| MXPA03008077A (es) | Composicion humedecedora para la piel.. | |
| MXPA03009409A (es) | Composicion herbicida. |